April 01, 2026 07:08 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengal SIR progress: 47 lakh of 60 lakh adjudicated cases disposed of, Supreme Court informed | Amit Shah to join Suvendu Adhikari on Bhabanipur nomination day; BJP plans mega roadshow | Fuel prices rise: Premium petrol, diesel hiked amid oil price surge | Commercial LPG up Rs 195.50 as global oil prices rise; domestic rates unchanged | Layoff alert: Oracle cuts 30,000 jobs globally, 12,000 hit in India | ‘Unsubstantial allegations’: Calcutta HC dismisses plea on ECI’s officer transfers in Bengal | Tennis icon Leander Paes joins BJP ahead of Bengal polls | 8 killed, several injured in crowd crush at Bihar temple in Nalanda | Trump signals exit from Iran war even as Strait of Hormuz remains shut: Report | Mystery death in Pakistan: JeM chief Masood Azhar’s brother found dead
Nepal
Image: Wikimedia Commons

Russia’s Sputnik-V given conditional approval in Nepal

| @indiablooms | Apr 21, 2021, at 10:58 pm

As Nepal struggles to procure vaccines from India, authorities in Nepal have given emergency use approval to Russia’s Sputnik-V Covid-19 vaccines, as per a report in the Kathmandu Post.

In a meeting on Tuesday, Nepal’s Department of Drug Administration decided to issue a conditional emergency use authorization to the vaccine, a statement released by the body says.

The approval came at a time when the South Asia region is witnessing a renewed wave across all its countries. So far, the government has given emergency use approvals to four vaccines.

“The company had applied for emergency use approval through the local supplier in Nepal, “ Santosh KC, the spokesperson for the department, was quoted as saying by The Kathmandu Post. “Based on the data provided by the suppliers of the company, we have given a conditional emergency use authorization,” he added.

The existing cold storage infrastructure in the country is sufficient for Sputnik-V which is required to be stored between 2 to 8-degree celsius. The Sputnik V vaccine’s efficacy is reported at 91.6 percent.

So far, around 1.8 million people have been vaccinated with Covishield while around 100,000 with Chinese Sinopharm. The government has already made an advance 80 percent payment to India SII for 5 million doses of Covishield. However, the SII is unlikely to supply any doses in the next one and half months.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.